Close
Almac
Achema middle east

USP opens new testing facility in India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

US FDA Approves Oral Antibiotic for Treatment of Gonorrhea

On December 12, 2025, the U.S. health regulator went...

BaseLaunch to Benefit from Biotech Innovation of Takeda

In one of the most prominent developments for the...
- Advertisement -

US Pharmacopeial Convention  has opened a new expanded testing facility in the IKP Knowledge Park in Hyderabad, India. The new facility will allow voluntary testing and auditing program that helps dietary supplement manufacturers ensure and attest to the production of quality products for consumers.USP’s new facility expands its presence from 14,000 square feet to over 100,000 square feet; the number of employees will go from 70 to 90 in the coming year.

USP CEO Roger Williams said they are now poised to do more collaborative testing, verification testing, pharmacopeial education, customer support, and sourcing of written and physical standards for drugs, much of which we have been doing in concert with Indian manufacturers.

Latest stories

Related stories

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

US FDA Approves Oral Antibiotic for Treatment of Gonorrhea

On December 12, 2025, the U.S. health regulator went...

BaseLaunch to Benefit from Biotech Innovation of Takeda

In one of the most prominent developments for the...

Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma

Pfizer has confirmed that it has struck an almost...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »